Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1718-1727

  Debret, Romain ^a   Brassart Pasco, Sylvie ^a   Lorin, Johanna ^a   Martoriati, Alain ^a   Deshorgue, Aurelie ^a   Maquart, François Xavier ^a   Hornebeck, William ^a   Rahman, Irfan ^a   Antonicelli, Frank ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Ceramide; HDAC; Invasion; Lung; MMP

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; C2 CERAMIDE; C6 CERAMIDE; CASPASE; CERAMIDE DERIVATIVE; GELATINASE A; GLUTATHIONE; HISTONE H3; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REACTIVE SULFUR SPECIES; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRONCHUS CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOGENESIS; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN TARGETING; TRANSCRIPTION REGULATION;

ACETYLATION; BRONCHIAL NEOPLASMS; CELL LINE; CERAMIDES; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PROTEASE INHIBITORS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 51749106985     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.06.001     Document Type: Article

References (54)

1. Selzner M., Bielawska A., Morse M.A., Rudiger H.A., Sindram D., Hannun Y.A., and Clavien P.A. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res 61 (2001) 1233-1240
2. Huwiler A., and Zangemeister-Wittke U. Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. Crit. Rev. Oncol. Hematol. 63 (2007) 150-159
3. Debret R., El Btaouri H., Duca L., Rahman I., Radke S., Haye B., Sallenave J.M., and Antonicelli F. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett. 546 (2003) 195-202
4. Kurinna S.M., Tsao C.C., Nica A.F., Jiffar T., and Ruvolo P.P. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res. 64 (2004) 7852-7856
5. Buisson-Legendre N., Bernard P., Bobichon H., Emonard H., Schneider C., Maquart F.X., Haye B., and Hornebeck W. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. Biochem. Biophys. Res. Commun. 260 (1999) 634-640
6. Reunanen N., Westermarck J., Hakkinen L., Holmstrom T.H., Elo I., Eriksson J.E., and Kahari V.M. Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273 (1998) 5137-5145
7. Sabatini M., Rolland G., Leonce S., Thomas M., Lesur C., Perez V., de Nanteuil G., and Bonnet J. Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage. Biochem. Biophys. Res. Commun. 267 (2000) 438-444
8. Abbott A. Cell culture: biology's new dimension. Nature 424 (2003) 870-872
9. Coussens L.M., Fingleton B., and Matrisian L.M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002) 2387-2392
10. Hornebeck W., Emonard H., Monboisse J.C., and Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol. 12 (2002) 231-241
11. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
12. Jones J.L., and Walker R.A. Control of matrix metalloproteinase activity in cancer. J. Pathol. 183 (1997) 377-379
13. Noel A., Emonard H., Polette M., Birembaut P., and Foidart J.M. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol. Res. Pract. 190 (1994) 934-941
14. Stuve O., Chabot S., Jung S.S., Williams G., and Yong V.W. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunol. 80 (1997) 38-46
15. Hrabec E., Strek M., Nowak D., Greger J., Suwalski M., and Hrabec Z. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J. Cancer Res. Clin. Oncol. 128 (2002) 197-204
16. Nenan S., Planquois J.M., Berna P., De Mendez I., Hitier S., Shapiro S.D., Boichot E., Lagente V., and Bertrand C.P. Analysis of the inflammatory response induced by rhMMP-12 catalytic domain instilled in mouse airways. Int. Immunopharmacol. 5 (2005) 511-524
17. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I.B., Enghild J.J., Sasaguri Y., and Mori Y. Degradation of interleukin 1beta by matrix metalloproteinases. J. Biol. Chem. 271 (1996) 14657-14660
18. Opdenakker G., Van den Steen P.E., and Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 22 (2001) 571-579
19. Nawrocki Raby B., Polette M., Gilles C., Clavel C., Strumane K., Matos M., Zahm J.M., Van Roy F., Bonnet N., and Birembaut P. Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int. J. Cancer 93 (2001) 644-652
20. Nawrocki B., Polette M., Marchand V., Monteau M., Gillery P., Tournier J.M., and Birembaut P. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses. Int. J. Cancer 72 (1997) 556-564
21. Polette M., Nawrocki B., Gilles C., Sato H., Seiki M., Tournier J.M., and Birembaut P. MT-MMP expression and localisation in human lung and breast cancers. Virchows Arch. 428 (1996) 29-35
22. Vinodhkumar R., Song Y.S., Ravikumar V., Ramakrishnan G., and Devaki T. Depsipeptide a histone deacetylase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Chem. Biol. Interact. 165 (2007) 220-229
23. Ntayi C., Labrousse A.L., Debret R., Birembaut P., Bellon G., Antonicelli F., Hornebeck W., and Bernard P. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J. Invest Dermatol. 122 (2004) 256-265
24. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J., and Klebe R.J. Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16 (1998) 483-496
25. Sasaki M., Kashima M., Ito T., Watanabe A., Izumiyama N., Sano M., Kagaya M., Shioya T., and Miura M. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha. Mediators Inflamm. 9 (2000) 155-160
26. Debret R., Le Naour R.R., Sallenave J.M., Deshorgue A., Hornebeck W.G., Guenounou M., Bernard P., and Antonicelli F.D. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J. Invest Dermatol. 126 (2006) 1860-1868
27. Rahman I., and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic. Biol. Med. 28 (2000) 1405-1420
28. Rosato R.R., Almenara J.A., and Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res. 63 (2003) 3637-3645
29. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., and Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58 (1998) 1048-1051
30. Martinella-Catusse C., Polette M., Noel A., Gilles C., Dehan P., Munaut C., Colige A., Volders L., Monboisse J.C., Foidart J.M., and Birembaut P. Down-regulation of MT1-MMP expression by the alpha3 chain of type IV collagen inhibits bronchial tumor cell line invasion. Lab. Invest 81 (2001) 167-175
31. Nawrocki-Raby B., Gilles C., Polette M., Martinella-Catusse C., Bonnet N., Puchelle E., Foidart J.M., Van Roy F., and Birembaut P. E-cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am. J. Pathol. 163 (2003) 653-661
32. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., and Arthur M.J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest 102 (1998) 538-549
33. Takai N., Ueda T., Kawano Y., Nishida M., Nasu K., and Narahara H. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma. Oncol. Rep. 14 (2005) 1287-1291
34. Preaux A.M., D'Ortho M.P., Bralet M.P., Laperche Y., and Mavier P. Apoptosis of human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology 36 (2002) 615-622
35. Emonard H., Bellon G., Troeberg L., Berton A., Robinet A., Henriet P., Marbaix E., Kirkegaard K., Patthy L., Eeckhout Y., Nagase H., Hornebeck W., and Courtoy P.J. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2.TIMP-2 complex through a thrombospondin-independent mechanism. J. Biol. Chem. 279 (2004) 54944-54951
36. Zorick T.S., Mustacchi Z., Bando S.Y., Zatz M., Moreira-Filho C.A., Olsen B., and Passos-Bueno M.R. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur. J. Hum. Genet. 9 (2001) 811-814
37. Andrieu-Abadie N., Gouaze V., Salvayre R., and Levade T. Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic. Biol. Med. 31 (2001) 717-728
38. Lavrentiadou S.N., Chan C., Kawcak T., Ravid T., Tsaba A., van der Vliet A., Rasooly R., and Goldkorn T. Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione. Am. J. Respir. Cell Mol. Biol. 25 (2001) 676-684
39. Liu B., and Hannun Y.A. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272 (1997) 16281-16287
40. Gutierrez G., Mendoza C., Montano L.F., and Lopez-Marure R. Ceramide induces early and late apoptosis in human papilloma virus + cervical cancer cells by inhibiting reactive oxygen species decay, diminishing the intracellular concentration of glutathione and increasing nuclear factor-kappaB translocation. Anticancer Drugs 18 (2007) 149-159
41. Bian J., and Sun Y. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17 (1997) 6330-6338
42. Qin H., Moellinger J.D., Wells A., Windsor L.J., Sun Y., and Benveniste E.N. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J. Immunol. 161 (1998) 6664-6673
43. Qin H., Sun Y., and Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274 (1999) 29130-29137
44. Swiderski R.E., Dencoff J.E., Floerchinger C.S., Shapiro S.D., and Hunninghake G.W. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152 (1998) 821-828
45. Bergman M.R., Cheng S., Honbo N., Piacentini L., Karliner J.S., and Lovett D.H. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem. J. 369 (2003) 485-496
46. Wang J.L., Sun Y., and Wu S. Gamma-irradiation induces matrix metalloproteinase II expression in a p53-dependent manner. Mol. Carcinog. 27 (2000) 252-258
47. Ma Z., Chang M.J., Shah R., Adamski J., Zhao X., and Benveniste E.N. Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene. J. Biol. Chem. 279 (2004) 46326-46334
48. Leslie M.C., and Bar-Eli M. Regulation of gene expression in melanoma: new approaches for treatment. J. Cell Biochem. 94 (2005) 25-38
49. Wu C. Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272 (1997) 28171-28174
50. Bannister A.J., and Miska E.A. Regulation of gene expression by transcription factor acetylation. Cell Mol. Life Sci. 57 (2000) 1184-1192
51. Glozak M.A., Sengupta N., Zhang X., and Seto E. Acetylation and deacetylation of non-histone proteins. Gene 363 (2005) 15-23
52. Polevoda B., and Sherman F. The diversity of acetylated proteins. Genome Biol. 3 (2002) reviews0006
53. Weiss C., Schneider S., Wagner E.F., Zhang X., Seto E., and Bohmann D. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J. 22 (2003) 3686-3695
54. Pulukuri S.M., Gorantla B., and Rao J.S. Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator. J. Biol. Chem. 282 (2007) 35594-35603